are between 0 and 1. The amino acid substitution is predicted damaging if the score is ≤0.05, and tolerated if the score is >0.05. Polyphen-2 prediction was calculated using the HumDiv model (used for evaluating rare alleles at loci potentially involved in complex phenotypes) with a false positive rate of 5%-10%, as the thresholds for ternary classification. Mutations are divided into benign, possibly damaging, or probably damaging and the cut-offs can be interpreted as follows: benign ranges between 0 and 0,15; possibly damaging ranges between 0,15 and 0,85; probably damaging ranges between 0,85 and 1.
(Thermofisher) and the cDNA conversion was performed with the SuperScript ® III First-Strand Synthesis System (Thermofisher). To evaluate the relative expression level of HSPB1, the RTqPCR was performed on the ViiA ™ 7 Real-Time PCR System (Thermofisher), using Power SYBR ® Master Mix (Thermofisher) according to manufacturer's instructions. The reactions were performed in triplicate, using four independent replicates. The expression level of HSPB1 was evaluated with qbase + software (Biogazelle), using the three most stable reference genes among GAPDH, HMBS, TBP, HPRT1 and SDHA.
Plasmids and stable cell lines preparation -The HSPB1 wild-type and mutant p.Ala204Glyfs*6 cDNA, including the 3'UTR, were purchased from GenArt (Thermofisher) and the constructs generated using the Gateway recombination system (Thermofisher). Since the frame-shift mutation determines the additional translation of 8 base pairs in the 3'UTR of the gene, we generated untagged proteins, in order to preserve the structure of the C-terminal domain. HSPB1 open reading frame was cloned in the pDONR221 vector and transferred by recombination to the pLenti6 destination vector (Thermofisher). Stable CHO-K1 cell lines were generated by Lentiviral transduction [Salmon and Trono, 2006] .
To evaluate the ability of HSPB1 to clear SOD1 p.Ala4Val aggregates, we generated double stable CHO-K1 cell lines expressing both SOD1 p.Ala4Val and HSPB1 wild-type or p.Ala204Glyfs*6, alternatively. The wild-type SOD1 plasmid was purchased from the plasmid repository DNASU (Biodesign Institute at Arizona State University, http://dnasu.asu.edu). The c.14C>T substitution was inserted with site direct mutagenesis on wild-type SOD1, resulting in the p.Ala4Val mutation according to the current SOD1 nomenclature. The plasmids were cloned into the pDONR221 and subsequently recombined in the pLenti6 destination vector, generating a GFP-fused protein (pLenti/GFP backbone available in house). All the plasmids were verified by Sanger sequencing.
Western Blotting -Cells were lysed in E1a lysis buffer (1% Nonidet P-40, 20 mM Hepes pH8, 250 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 2 mM DTT, 4 mM Sodium orthovanadate, 20 mM Glycerol-2-Phosphate, 10 mM Sodium Fluoride, 1 mM Sodium Pyrophosphate, together with the 3 complete protease and the Phospho-STOP inhibitor mixtures -Roche Applied Science) for 30 min on ice and cleared by centrifugation (14000 rpm for 10 min). For the SOD1 clearance assay, the supernatant was collected after the first centrifugation. The pellet fraction was lysed in E1a and sonicated for 15 sec. After Bradford quantification, the lysates were boiled for 5 min at 95°C in SDS loading buffer (LB) (Thermofisher) supplemented with 100 mM DTT (reducing condition). To detect HSPB1 dimers on the Western blots, cell lysates were boiled in non-reducing SB. Mouse monoclonal anti-HSPB1 antibody was purchased from Stressgen, mouse monoclonal anti-HSF1
was purchased from Santa Cruz Biotechnology, mouse monoclonal anti-ubiquitin (ubiquitinated proteins) was purchased from Cell Signaling, rabbit polyclonal anti-LC3 was purchased from Cell
Signaling, mouse monoclonal anti-GFP (Jl-8) was purchased from Clontech, mouse monoclonal anti-actin was purchased from Sigma-Aldrich and rabbit polyclonal anti-GAPDH was purchased from GeneTex.
Supp. Figure S1: HSPB1 expression in LCLs
The expression of HSPB1 was evaluated at both mRNA and protein level in patient-derived EBV- Supp. 
